Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
Nathaniel D. Anderson(Wellcome Sanger Institute), Adam Shlien(Hospital for Sick Children), Moritz Gerstung(European Bioinformatics Institute), Huayun Hou(Hospital for Sick Children), Matthew Zatzman(University of Toronto), Fabio Fuligni(Hospital for Sick Children), Marcus Q. Bernardini(University Health Network), Marjan Rouzbahman(University Health Network), Carol J. Swallow(University Health Network), Sheena Guram(University College Hospital), Rebecca A. Gladdy(Princess Margaret Cancer Centre), Peter C. Ferguson(University of Toronto), James J. Dowling(Maine Farmland Trust), Rima Al‐awar(Ontario Institute for Cancer Research), Kyoko E. Yuki(McGill University), Federico Comitani(Hospital for Sick Children), Irene L. Andrulis(University of Toronto), Nicholas Light(University of Toronto), Yael Babichev(Mount Sinai Hospital), Daniel Durocher(University of Toronto), Brendan C. Dickson(Sinai Health System), Claire Wunker(Mount Sinai Hospital), Ludmil B. Alexandrov(UC San Diego Health System), Stefan C. Dentro(The Francis Crick Institute), Anant Maheshwari(Wellcome Sanger Institute), John Thompson(Hospital for Sick Children), Mehdi Layeghifard(Hospital for Sick Children), Albiruni R. Abdul Razak(Mount Sinai Hospital), Rosemarie E. Venier(University of Toronto), Richard Marcellus(Ontario Institute for Cancer Research), Jay S. Wunder(Sinai Health System)
Cited by 64
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k